Event: PLN 1.8 million subsidy to buy the production line
On Monday morning, BioMaxima informed that it acquired a PLN 1.8 million subsidy to buy a modern fully automatic production line for tests identifying SARS-COV-2. The subsidy constitutes 60% of eligible costs, the line will be delivered in 1Q23.
Expected impact: Positive; the information was discounted during Monday’s WSE trading. Still, we wonder how vital would be the expansion of production capacities regarding testing SARS-COV-2, while a contribution of this type of diagnostic services fell to 3% of revenues in 3Q22.
Analyst Sylwia Jaśkiewicz, CFA, Mikołaj Stępień
This report is prepared for the Warsaw Stock Exchange SA within the framework of the Analytical Coverage Support Program 3.0.
Daily, January 18, 2023
